Relevance of IL7R genotype and mRNA expression in Dutch patients with multiple sclerosis

Multiple Sclerosis Journal

Volumn 17, Issue 8, 2011, Pages 922-930

  Sombekke, M H ^a   Van Der Voort, L F ^a   Kragt, J J ^a   Nielsen, J M ^a   Guzel, H ^a   Visser, A ^a   Oudejans, C B M ^a   Crusius, J B A ^a   Peña, A Salvador ^a   Vrenken, H ^a   Polman, C H ^a   Killestein, J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

genetics; genotype; IL7R; MRI; mRNA; multiple sclerosis; phenotype

Indexed keywords

INTERLEUKIN 7 RECEPTOR; MESSENGER RNA;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE PREDISPOSITION; DISEASE SEVERITY; DNA DETERMINATION; FEMALE; GENE FREQUENCY; GENOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEOTIDE SEQUENCE; PHENOTYPE; POPULATION RESEARCH; PROTEIN EXPRESSION; RISK ASSESSMENT;

EID: 80052014397     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458511402411     Document Type: Article

References (37)

1. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. N Engl J Med. 2000 ; 343: 938-952
2. Handunnetthi L, Ramagopalan SV, Ebers GC. Multiple sclerosis, vitamin D, and HLA-DRB1*15. Neurology. 2010 ; 74: 1905-1910
3. Ramagopalan SV, Dobson R, Meier UC, Giovannoni G. Multiple sclerosis: risk factors, prodromes, and potential causal pathways. Lancet Neurol. 2010 ; 9: 727-739
4. De Jager PL, Simon KC, Munger KL, Rioux JD, Hafler DA, Ascherio A. Integrating risk factors: HLA-DRB1*1501 and Epstein-Barr virus in multiple sclerosis. Neurology. 2008 ; 70: 1113-1118 (Pubitemid 351464768)
5. Barcellos LF, Oksenberg JR, Begovich AB, Martin ER, Schmidt S, Vittinghoff E, et al. HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course. Am J Hum Genet. 2003 ; 72: 710-716 (Pubitemid 36255969)
6. Aulchenko YS, Hoppenbrouwers IA, Ramagopalan SV, Broer L, Jafari N, Hillert J, et al. Genetic variation in the KIF1B locus influences susceptibility to multiple sclerosis. Nat Genet. 2008 ; 40: 1402-1403
7. De Jager PL, Jia X, Wang J, de Bakker PI, Ottoboni L, Aggarwal NT, et al. Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat Genet. 2009 ; 41: 776-782
8. Gregory SG, Schmidt S, Seth P, Oksenberg JR, Hart J, Prokop A, et al. Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis. Nat Genet. 2007 ; 39: 1083-1091 (Pubitemid 47340652)
9. Hafler DA, Compston A, Sawcer S, Lander ES, Daly MJ, De Jager PL, et al. Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med. 2007 ; 357: 851-862 (Pubitemid 47347319)
10. Lundmark F, Duvefelt K, Iacobaeus E, Kockum I, Wallstrom E, Khademi M, et al. Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis. Nat Genet. 2007 ; 39: 1108-1113 (Pubitemid 47340654)
11. Akkad DA, Hoffjan S, Petrasch-Parwez E, Beygo J, Gold R, Epplen JT. Variation in the IL7RA and IL2RA genes in German multiple sclerosis patients. J Autoimmun. 2009 ; 32: 110-115
12. D'Netto MJ, Ward H, Morrison KM, Ramagopalan SV, Dyment DA, DeLuca GC, et al. Risk alleles for multiple sclerosis in multiplex families. Neurology. 2009 ; 72: 1984-1988
13. Weber F, Fontaine B, Cournu-Rebeix I, Kroner A, Knop M, Lutz S, et al. IL2RA and IL7RA genes confer susceptibility for multiple sclerosis in two independent European populations. Genes Immun. 2008 ; 9: 259-263 (Pubitemid 351584192)
14. O'Doherty C, Kantarci O, Vandenbroeck K. IL7RA polymorphisms and susceptibility to multiple sclerosis. N Engl J Med. 2008 ; 358: 753-754 (Pubitemid 351240775)
15. Alcina A, Fedetz M, Ndagire D, Fernandez O, Leyva L, Guerrero M, et al. The T244I variant of the interleukin-7 receptor-alpha gene and multiple sclerosis. Tissue Antigens. 2008 ; 72: 158-161 (Pubitemid 352009810)
16. Ebers GC, Kukay K, Bulman DE, Sadovnick AD, Rice G, Anderson C, et al. A full genome search in multiple sclerosis. Nat Genet. 1996 ; 13: 472-476 (Pubitemid 26256624)
17. Korte A, Kochling J, Badiali L, Eckert C, Andreae J, Geilen W, et al. Expression analysis and characterization of alternatively spliced transcripts of human IL-7Ralpha chain encoding two truncated receptor proteins in relapsed childhood ALL. Cytokine. 2000 ; 12: 1597-1608
18. McKay FC, Swain LI, Schibeci SD, Rubio JP, Kilpatrick TJ, Heard RN, et al. Haplotypes of the interleukin 7 receptor alpha gene are correlated with altered expression in whole blood cells in multiple sclerosis. Genes Immun. 2008 ; 9: 1-6 (Pubitemid 351150028)
19. Evsyukova I, Somarelli JA, Gregory SG, Garcia-Blanco MA. Alternative splicing in multiple sclerosis and other autoimmune diseases. RNA Biol. 2010 ; 7: 462-473
20. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001 ; 50: 121-127
21. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983 ; 13: 227-231 (Pubitemid 13158528)
22. Schrijver HM, Crusius JB, Garcia-Gonzalez MA, Polman CH, Pena AS, Barkhof F, et al. Gender-related association between the TGFB1+869 polymorphism and multiple sclerosis. J Interferon Cytokine Res. 2004 ; 24: 536-542 (Pubitemid 39244542)
23. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology. 1983 ; 33: 1444-1452 (Pubitemid 14237132)
24. Roxburgh RH, Seaman SR, Masterman T, Hensiek AE, Sawcer SJ, Vukusic S, et al. Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity. Neurology. 2005 ; 64: 1144-1151
25. Cutter GR, Baier ML, Rudick RA, Cookfair DL, Fischer JS, Petkau J, et al. Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain. 1999 ; 122: 871-882 (Pubitemid 29219261)
26. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001 ; 25: 402-408 (Pubitemid 34164012)
27. Bosma LV, Kragt JJ, Brieva L, Khaleeli Z, Montalban X, Polman CH, et al. Progression on the Multiple Sclerosis Functional Composite in multiple sclerosis: what is the optimal cut-off for the three components?. Mult Scler. 2010 ; 16: 862-867
28. Goodkin DE. EDSS reliability. Neurology. 1991 ; 41: 332-332
29. Heron M, Grutters JC, van Moorsel CH, Ruven HJ, Huizinga TW, van der Helm-van Mil AH, Claessen AM, et al. Variation in IL7R predisposes to sarcoid inflammation. Genes Immun. 2009 ; 10: 647-653
30. Jensen CJ, Stankovich J, Van der Walt A, Bahlo M, Taylor BV, van der Mei IA, et al. Multiple sclerosis susceptibility-associated SNPs do not influence disease severity measures in a cohort of Australian MS patients. Plos One. 2010 ; 5 :
31. Baranzini SE, Wang J, Gibson RA, Galwey N, Naegelin Y, Barkhof F, et al. Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. Hum Mol Genet. 2009 ; 18: 767-778
32. Sombekke MH, Arteta D, van de Wiel MA, Crusius JB, Tejedor D, Killestein J, et al. Analysis of multiple candidate genes in association with phenotypes of multiple sclerosis. Mult Scler. 2010 ; 16: 652-659
33. Masterman T, Ligers A, Olsson T, Andersson M, Olerup O, Hillert J. HLA-DR15 is associated with lower age at onset in multiple sclerosis. Ann Neurol. 2000 ; 48: 211-219 (Pubitemid 30617040)
34. Hensiek AE, Sawcer SJ, Feakes R, Deans J, Mander A, Akesson E, et al. HLA-DR 15 is associated with female sex and younger age at diagnosis in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2002 ; 72: 184-187
35. Hauser SL, Oksenberg JR, Lincoln R, Garovoy J, Beck RW, Cole SR, et al. Interaction between HLA-DR2 and abnormal brain MRI in optic neuritis and early MS. Optic Neuritis Study Group. Neurology. 2000 ; 54: 1859-1861 (Pubitemid 30428420)
36. Okuda DT, Srinivasan R, Oksenberg JR, Goodin DS, Baranzini SE, Beheshtian A et al. Genotype-Phenotype correlations in Multiple Sclerosis: "HLA" genes influence disease severity inferred by 1HMR spectroscopy and MRI measures. Brain 2009; 132(Pt 1): 250-259.
37. Whitney AR, Diehn M, Popper SJ, Alizadeh AA, Boldrick JC, Relman DA, et al. Individuality and variation in gene expression patterns in human blood. Proc Natl Acad Sci U S A. 2003 ; 100: 1896-1901 (Pubitemid 36254545)